Related Experiment Video

Updated: Jul 13, 2026

Murine Cervical Aortic Transplantation Model using a Modified Non-Suture Cuff Technique
10:11

Murine Cervical Aortic Transplantation Model using a Modified Non-Suture Cuff Technique

Published on: November 2, 2019

Cardiovascular disease posttransplant

Phuong-Thu T Pham1, Phuong-Chi T Pham, Gabriel M Danovitch

  • 1Division of Nephrology, Kidney and Pancreas Transplantation, Department of Medicine, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA 90095, USA. ppham@mednet.ucla.edu

Seminars in Nephrology
|July 10, 2007
PubMed

Insights

Kidney transplantation improves survival for end-stage renal disease patients but carries cardiac risks. Managing these cardiovascular complications is crucial for long-term transplant success.

Area of Science:

  • Nephrology
  • Cardiology
  • Transplantation Medicine

Background:

  • Renal transplantation is the primary treatment for end-stage renal disease, enhancing survival and quality of life over dialysis.
  • Despite benefits, post-transplant cardiac complications significantly increase morbidity and mortality in kidney transplant recipients.
  • Cardiovascular mortality is notably higher in transplant recipients compared to the general population, especially in younger age groups.

Purpose of the Study:

  • To review conventional and novel cardiovascular disease risk factors following renal transplantation.
  • To discuss current medical management strategies for these identified cardiovascular risks.
  • To provide an evidence-based overview for clinicians managing kidney transplant patients.

Main Methods:

  • Comprehensive literature review of studies on cardiovascular complications post-renal transplantation.
  • Analysis of risk factors, including those related to immunosuppressive medications.
  • Synthesis of data on patient outcomes and management approaches.

Main Results:

  • Renal transplantation improves some cardiovascular disease risk factors by restoring kidney function.
  • Immunosuppressive therapies introduce unique cardiovascular risks in transplant recipients.
  • Elevated cardiovascular mortality rates observed in transplant recipients across various age demographics.

Conclusions:

  • Post-renal transplantation requires vigilant monitoring and management of cardiovascular risks.
  • A multifaceted approach addressing both traditional and transplant-specific risk factors is essential.
  • Optimizing cardiovascular health is critical for improving long-term outcomes in kidney transplant recipients.

More Related Videos

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique10:32

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique

Published on: October 12, 2014

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...